ATH 33.3% 0.4¢ alterity therapeutics limited

PBT2 News, page-20

  1. 516 Posts.
    lightbulb Created with Sketch. 13
    You are right. ATH had also assured there was no resource spared for PBT2 when they were focusing on developing ATH434 last year.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.